Stifel Financial Corp Has $742,000 Holdings in VanEck Pharmaceutical ETF (NASDAQ:PPH)

Stifel Financial Corp boosted its stake in VanEck Pharmaceutical ETF (NASDAQ:PPH) by 13.4% in the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 7,810 shares of the company’s stock after purchasing an additional 924 shares during the period. Stifel Financial Corp’s holdings in VanEck Pharmaceutical ETF were worth $742,000 at the end of the most recent reporting period.

Other large investors have also bought and sold shares of the company. Townsquare Capital LLC boosted its stake in shares of VanEck Pharmaceutical ETF by 3.8% in the 3rd quarter. Townsquare Capital LLC now owns 3,519 shares of the company’s stock valued at $334,000 after purchasing an additional 130 shares during the last quarter. FMR LLC lifted its holdings in VanEck Pharmaceutical ETF by 12.5% in the third quarter. FMR LLC now owns 1,905 shares of the company’s stock valued at $181,000 after buying an additional 212 shares during the period. Beck Capital Management LLC boosted its position in VanEck Pharmaceutical ETF by 1.5% during the second quarter. Beck Capital Management LLC now owns 21,274 shares of the company’s stock valued at $1,946,000 after acquiring an additional 317 shares during the last quarter. Assetmark Inc. grew its holdings in VanEck Pharmaceutical ETF by 5.8% during the 3rd quarter. Assetmark Inc. now owns 6,491 shares of the company’s stock worth $617,000 after acquiring an additional 354 shares during the period. Finally, Harbour Investments Inc. raised its position in shares of VanEck Pharmaceutical ETF by 16.6% in the 3rd quarter. Harbour Investments Inc. now owns 3,425 shares of the company’s stock worth $325,000 after acquiring an additional 488 shares in the last quarter.

VanEck Pharmaceutical ETF Price Performance

Shares of NASDAQ:PPH opened at $87.70 on Wednesday. The business’s 50-day moving average is $89.96 and its 200-day moving average is $92.83. VanEck Pharmaceutical ETF has a 1 year low of $80.57 and a 1 year high of $99.51. The company has a market capitalization of $648.10 million, a price-to-earnings ratio of 21.04 and a beta of 0.72.

About VanEck Pharmaceutical ETF

The VanEck Pharmaceutical ETF (PPH) is an exchange-traded fund that is based on the MVIS US Listed Pharmaceutical 25 index, a market-cap-weighted index of 25 of the largest global pharmaceutical firms. PPH was launched on Feb 1, 2000 and is managed by VanEck.